Alzamend Neuro Inc (NASDAQ:ALZN) price on Thursday, July 03, fall -2.00% below its previous day’s close as a downside momentum from buyers pushed the stock’s value to $2.94.
A look at the stock’s price movement, the close in the last trading session was $3.0, moving within a range at $2.9 and $3.035. The beta value (5-Year monthly) was -0.277. Turning to its 52-week performance, $135.54 and $2.75 were the 52-week high and 52-week low respectively. Overall, ALZN moved -23.24% over the past month.
Alzamend Neuro Inc’s market cap currently stands at around $2.35 million, with investors looking forward to this quarter’s earnings report slated for on 2025-Mar-10.
Turning to the stock’s technical picture we see that short term indicators suggest on average that ALZN is a 100% Sell. On the other hand, the stock is on average a 100% Sell as suggested by medium term indicators while long term indicators are putting the stock in 100% Sell category.
1 analyst(s) have given their forecast ratings for the stock on a scale of 1.00-5.00 for a strong buy to strong sell recommendation. A total of 0 analyst(s) rate the stock as a Hold, 1 recommend ALZN as a Buy and 0 give it an Overweight rating. Meanwhile, 0 analyst(s) rate the stock as Underweight and 0 say it is a Sell. As such, the average rating for the stock is Buy which could provide an opportunity for investors keen on increasing their holdings of the company’s stock.
ALZN’s current price about -5.72% and -27.91% off the 20-day and 50-day simple moving averages respectively. The Relative Strength Index (RSI, 14) currently prints 38.28, while 7-day volatility ratio is 4.87% and 6.63% in the 30-day chart. Further, Alzamend Neuro Inc (ALZN) has a beta value of -0.32.
If we refocus on Alzamend Neuro Inc (NASDAQ:ALZN), historical trading data shows that trading volumes averaged 0.22 over the past 10 days and 1.62 million over the past 3 months. The company’s latest data on shares outstanding shows there are 0.80 million shares.
The 2.65% of Alzamend Neuro Inc’s shares are in the hands of company insiders while institutional holders own 0.88% of the company’s shares. Also important is the data on short interest which shows that short shares stood at 0.14 million on 2025-06-13, giving us a short ratio of 0.03. The data shows that as of 2025-06-13 short interest in Alzamend Neuro Inc (ALZN) stood at 1748.9999999999998 of shares outstanding, with shares short falling to 0.15 million registered in 2025-05-15. Current price change has pushed the stock -92.01% YTD, which shows the potential for further growth is there. It is this reason that could see investor optimism for the ALZN stock continues to rise going into the next quarter.
